ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 144 filers reported holding ESPERION THERAPEUTICS INC NE in Q2 2021. The put-call ratio across all filers is 2.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $85,832 | -29.5% | 87,584 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $121,741 | -12.6% | 87,584 | 0.0% | 0.00% | -50.0% |
| Q1 2023 | $139,258 | -74.4% | 87,584 | +0.2% | 0.00% | -66.7% |
| Q4 2022 | $544,402 | -44.0% | 87,384 | -39.8% | 0.01% | -40.0% |
| Q3 2022 | $973,000 | -12.8% | 145,245 | -17.3% | 0.01% | -9.1% |
| Q2 2022 | $1,116,000 | +32.5% | 175,669 | -3.3% | 0.01% | +37.5% |
| Q1 2022 | $842,000 | +10.2% | 181,701 | +18.8% | 0.01% | +14.3% |
| Q4 2021 | $764,000 | -46.0% | 152,932 | +30.2% | 0.01% | -41.7% |
| Q3 2021 | $1,415,000 | -12.2% | 117,500 | +54.2% | 0.01% | 0.0% |
| Q2 2021 | $1,611,000 | +4781.8% | 76,200 | +6250.0% | 0.01% | – |
| Q1 2021 | $33,000 | – | 1,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $20,735,000 | 8.65% |
| Altium Capital Management LP | 2,496,524 | $11,584,000 | 3.88% |
| Deep Track Capital, LP | 6,000,000 | $27,840,000 | 1.78% |
| Paradigm Biocapital Advisors LP | 1,157,246 | $5,370,000 | 1.42% |
| Monaco Asset Management SAM | 419,262 | $1,945,000 | 0.77% |
| Rhenman & Partners Asset Management AB | 981,582 | $4,555,000 | 0.45% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,713,176 | $12,589,000 | 0.39% |
| Bellevue Group AG | 4,299,164 | $19,948,000 | 0.23% |
| WASATCH ADVISORS LP | 8,147,380 | $37,804,000 | 0.19% |
| Telemetry Investments, L.L.C. | 17,500 | $81,000 | 0.13% |